Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 16,674,766
- Estimated value
- $13,211,417
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- Shares held by ElevateBio LLC
Morana Jovan-Embiricos - Director at Kalaris Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- KLRS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Morana Jovan-Embiricos since 14 Oct 2025
Reported holdings for Morana Jovan-Embiricos in Kalaris Therapeutics, Inc.
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 4,193,874
- Estimated value
- $3,322,806
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- F2 Capital I 2020 LLC
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 2,059,884
- Estimated value
- $1,632,046
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- F2 MG Ltd.
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 2,038,583
- Estimated value
- $1,615,169
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- Shares held by F2 MC, LLC
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 867,678
- Estimated value
- $687,461
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- F2 Bioscience AV 2022 LLC
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 668,072
- Estimated value
- $529,313
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- Shares held by F2 TPO Investments, LLC
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 100,197
- Estimated value
- $79,386
- Report date
- 06 Jun 2024
- Price
- $0.7923
- Ownership
- Direct
Form 4 holding
Director
Kalaris Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 9,000
- Estimated value
- Report date
- 03 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Morana Jovan-Embiricos in Kalaris Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.